These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12377563)

  • 21. Variation-tolerant capture and multiplex detection of nucleic acids: application to detection of microbes.
    Ohrmalm C; Eriksson R; Jobs M; Simonson M; Strømme M; Bondeson K; Herrmann B; Melhus A; Blomberg J
    J Clin Microbiol; 2012 Oct; 50(10):3208-15. PubMed ID: 22814465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid clinical bacteriology and its future impact.
    van Belkum A; Durand G; Peyret M; Chatellier S; Zambardi G; Schrenzel J; Shortridge D; Engelhardt A; Dunne WM
    Ann Lab Med; 2013 Jan; 33(1):14-27. PubMed ID: 23301218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current applications and future trends of molecular diagnostics in clinical bacteriology.
    Weile J; Knabbe C
    Anal Bioanal Chem; 2009 Jun; 394(3):731-42. PubMed ID: 19377839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Targeted Next-Generation Sequencing for Detection of Bovine Pathogens in Clinical Samples.
    Anis E; Hawkins IK; Ilha MRS; Woldemeskel MW; Saliki JT; Wilkes RP
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29695524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges.
    Arena F; Giani T; Pollini S; Viaggi B; Pecile P; Rossolini GM
    Future Microbiol; 2017 Apr; 12():361-364. PubMed ID: 28361554
    [No Abstract]   [Full Text] [Related]  

  • 26. Automated Broad-Range Molecular Detection of Bacteria in Clinical Samples.
    Budding AE; Hoogewerf M; Vandenbroucke-Grauls CM; Savelkoul PH
    J Clin Microbiol; 2016 Apr; 54(4):934-43. PubMed ID: 26763956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forty Years of Molecular Diagnostics for Infectious Diseases.
    Schmitz JE; Stratton CW; Persing DH; Tang YW
    J Clin Microbiol; 2022 Oct; 60(10):e0244621. PubMed ID: 35852340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paper microfluidics for nucleic acid amplification testing (NAAT) of infectious diseases.
    Magro L; Escadafal C; Garneret P; Jacquelin B; Kwasiborski A; Manuguerra JC; Monti F; Sakuntabhai A; Vanhomwegen J; Lafaye P; Tabeling P
    Lab Chip; 2017 Jul; 17(14):2347-2371. PubMed ID: 28632278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of molecular diagnostics in the management of infectious disease emergencies.
    Krishna NK; Cunnion KM
    Med Clin North Am; 2012 Nov; 96(6):1067-78. PubMed ID: 23102477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The possibilities and limitations of nucleic acid amplification technology in diagnostic microbiology.
    Vaneechoutte M; Van Eldere J
    J Med Microbiol; 1997 Mar; 46(3):188-94. PubMed ID: 9126818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing molecular microbiology facilities in developing countries.
    Ahmed SS; Alp E; Ulu-Kilic A; Doganay M
    J Infect Public Health; 2015; 8(6):513-25. PubMed ID: 26116452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious diseases testing.
    Blakey GL; Luna RA; Versalovic J
    Curr Protoc Hum Genet; 2005 Nov; Chapter 9():Unit 9.18. PubMed ID: 18428383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newer methods for microbiologic diagnosis of pediatric infections.
    Rodrigues C; Shetty A
    Indian J Pediatr; 2011 Feb; 78(2):185-91. PubMed ID: 21082362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loop-mediated isothermal amplification technology: towards point of care diagnostics.
    Njiru ZK
    PLoS Negl Trop Dis; 2012; 6(6):e1572. PubMed ID: 22745836
    [No Abstract]   [Full Text] [Related]  

  • 35. New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance.
    Tsalik EL; Bonomo RA; Fowler VG
    Annu Rev Med; 2018 Jan; 69():379-394. PubMed ID: 29414265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving the treatment of musculoskeletal infections with molecular diagnostics.
    Tarkin IS; Dunman PM; Garvin KL
    Clin Orthop Relat Res; 2005 Aug; (437):83-8. PubMed ID: 16056030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct detection of markers associated with Neisseria gonorrhoeae antimicrobial resistance in New Zealand using residual DNA from the Cobas 4800 CT/NG NAAT assay.
    Nicol M; Whiley D; Nulsen M; Bromhead C
    Sex Transm Infect; 2015 Mar; 91(2):91-3. PubMed ID: 25365962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic microbiology and therapeutic drug monitoring in pediatric infectious diseases.
    Jacobs MR; Myers C
    Pediatr Clin North Am; 1983 Feb; 30(1):135-59. PubMed ID: 6338461
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of sensitivity and rapid hybridization of a multiplexed Microbial Detection Microarray.
    Thissen JB; McLoughlin K; Gardner S; Gu P; Mabery S; Slezak T; Jaing C
    J Virol Methods; 2014 Jun; 201():73-8. PubMed ID: 24602557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial identification in the diagnostic laboratory: how much is enough?
    Kootallur BN; Thangavelu CP; Mani M
    Indian J Med Microbiol; 2011; 29(4):336-40. PubMed ID: 22120791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.